Shanghai medical device company developing drug-coated coronary balloon catheters and embolization systems, founded in 2014.
Sqmedical was established in 2014 and is based in Shanghai, China. It develops vascular minimally invasive interventional devices, including drug-coated coronary balloon catheters and detachable spring coil embolization systems with fiber hair. Its products are used in cardiovascular, structural heart, peripheral vascular and neurovascular intervention. In August 2020 it raised strategic investment of approximately CNY 100 million led by new investors Lyfe Capital and GL Ventures, with returning investors 3H Health Investment and Apricot Capital. It is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in